Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A 50-g oral glucose challenge test (OGCT) is a widely accepted screening method for gestational diabetes mellitus (GDM), but other options are being considered. PURPOSE: To systematically review the test characteristics of various screening methods for GDM across a range of recommended diagnostic glucose thresholds. DATA SOURCES: 15 electronic databases from 1995 to May 2012, reference lists, Web sites of relevant organizations, and gray literature. STUDY SELECTION: Two reviewers independently identified English-language prospective studies that compared any screening test for GDM with any reference standard. DATA EXTRACTION: One reviewer extracted and a second reviewer verified data from 51 cohort studies. Two reviewers independently assessed methodological quality. DATA SYNTHESIS: The sensitivity, specificity, and positive and negative likelihood ratios for the OGCT at a threshold of 7.8 mmol/L (140 mg/dL) were 70% to 88%, 69% to 89%, 2.6 to 6.5, and 0.16 to 0.33, respectively. At a threshold of 7.2 mmol/L (130 mg/dL), the test characteristics were 88% to 99%, 66% to 77%, 2.7 to 4.2, and 0.02 to 0.14, respectively. For a fasting plasma glucose threshold of 4.7 mmol/L (85 mg/dL), they were 87%, 52%, 1.8, and 0.25, respectively. Glycated hemoglobin level had poorer test characteristics than fasting plasma glucose level or the OGCT. No studies compared the OGCT with International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. LIMITATIONS: The lack of a gold standard for confirming GDM limits comparisons. Few data exist for screening tests before 24 weeks' gestation. CONCLUSION: The OGCT and fasting plasma glucose level (at a threshold of 4.7 mmol/L [85 mg/dL]) by 24 weeks' gestation are good at identifying women who do not have GDM. The OGCT is better at identifying women who have GDM. The OGCT has not been validated for the IADPSG diagnostic criteria.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review from the U.S. Preventive Services Task Force in 2013 demonstrated that the GCT is acceptable as a screening test [16].”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [16]
In the citing paper
“A 2013 systematic review of screening cutoffs estimated the sensitivity and specificity of the various cutoffs, using the 100 g, 3hour OGTT as the gold standard, as 140 mg/dL (70% to 88% sensitivity, 69% to 89% specificity) and 130 mg/dL (88% to 99% sensitivity, 66% to 77% specificity).13”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [13]
In the citing paper
“Based on specificity figures from a 2013 systematic review, 13 when a screening threshold of 140 mg/dL is used, between 11% and 31% of women will have false positive screens and require the full 100 g, 3-hour OGTT, whereas, for a threshold of 130 mg/dL, 23% to 34% will need the diagnostic OGTT.”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [13]
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“Some stakeholders have recommended a 1-step diagnostic test for GDM because it results in a more rapid diagnosis of affected women (12); however, this approach has not been shown to be cost-effective (13).”
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369 · cited 1×
“If there were more than 3 studies and they were clinically homogeneous (that is, they included women at 24 or 24 weeks’ gestation and used similar thresholds and diagnostic criteria), we pooled the data by using a hierarchical summary receiver-operating characteristic curve (HSROC) and bivariate analysis of sensitivit…”
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
Jaeschke, R. (1994) · JAMA · doi:10.1001/jama.1994.03510330081039 · Cited by 2,209 · cited 1×
“larger the positive LR, the greater the accuracy of the test and the greater the likelihood of disease after a positive test result; the smaller the negative LR, the smaller the likelihood of disease after a negative test result (19).”
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
Research works printed but not linked: 15
- Kashi Z, 2007, International Journal of Endocrinology & Metabolism, 5, 1
- Sacks DA, 2003, Obstet Gynecol, 101, 1197
- Uncu G, 1995, Clin Exp Obstet Gynecol, 22, 230
- 10.1111/j.0001-6349.2005.00650.x · doi:10.1111/j.0001-6349.2005.00650.x · Paper page
- 10.1177/014107680209500903 · doi:10.1177/014107680209500903
- Ardawi MS, 2000, Saudi Med J, 21, 155
- Siribaddana SH, 1998, Ceylon Med J, 43, 88
- Eslamian L, 2008, Acta Med Iran, 46, 43
- Bobrowski RA, 1996, J Matern Fetal Med, 5, 317
- 10.1111/j.0001-6349.2005.00670.x · doi:10.1111/j.0001-6349.2005.00670.x · Paper page
- Rust O, 1998, J Perinatol, 18, 49
- Brustman LE, 1995, J Assoc Acad Minor Phys, 6, 70
- Sermer M, 1998, Diabetes Care, 21, B33
- Farrar D, 2011, Cochrane Database Syst Rev, CD007122
- Tieu J, 2010, Cochrane Database Syst Rev, CD007222
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Donovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M.
- Affiliations
- University of Alberta (CA)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2013-07
- Volume
- 159
- Issue
- 2
- Pages
- 115-122
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2035934005
- Semantic Scholar
- d755515f74cbc8b5b7255dddf01efe64f0b4fb3e
- Cited by
- 125
- References
- 83
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 3 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 13 · 2017: 10 · 2016: 9 · 2015: 13 · 2014: 10 · 2013: 6
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290-2007-10021-I)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, screening test, oral glucose challenge test, fasting blood glucose, HbA1c, diagnostic accuracy, IADPSG criteria, prenatal screening
- MeSH terms
- Blood Glucose, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Mass Screening, Pregnancy, ROC Curve, Sensitivity and Specificity, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force. https://app.cochat.ai/papers/10.7326/0003-4819-159-2-201307160-00657
- The paper
- Donovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M. (2013). Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-159-2-201307160-00657
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.